Trial intelligence / Profile preview

VALID 0 palatability testing of paediatric valacyclovir formulations

2012-000577-22Phase 4Completed

Sponsor
Radboud University Medical Center
Start
Jan 2013
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 4 trial of valaciclovir in herpes simplex (HSV), Varicella zoster infection, cytomegalovirus disease (CMV), sponsored by Radboud University Medical Center. Started Jan 2013; status: completed.

02

Drugs

valaciclovir
03

Conditions

herpes simplex (HSV)Varicella zoster infectioncytomegalovirus disease (CMV)

Beyond the preview

Go deeper on 2012-000577-22.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-000577-22.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call